Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000863749 | SCV001004459 | benign | X-linked Emery-Dreifuss muscular dystrophy | 2024-11-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001638001 | SCV001849849 | benign | not provided | 2020-01-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002352515 | SCV002655849 | likely benign | Cardiovascular phenotype | 2019-02-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001830870 | SCV002084707 | benign | Emery-Dreifuss muscular dystrophy | 2020-04-11 | no assertion criteria provided | clinical testing |